TargetMol

Teriflunomide

Product Code:
 
TAR-T7534
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7534-10mg10mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7534-50mg50mg£117.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7534-100mg100mg£143.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7534-500mg500mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Teriflunomide is the principal active metabolite of leflunomide, an approved therapy for rheumatoid arthritis and multiple sclerosis.
CAS:
163451-81-8
Formula:
C12H9F3N2O2
Molecular Weight:
270.21
Purity:
0.9995
SMILES:
C/C(O)=C(C#N)C(=O)Nc1ccc(C(F)(F)F)cc1

References

He D , Xu Z , Dong S , et al. Teriflunomide for multiple sclerosis[J]. Cochrane database of systematic reviews (Online), 2012, 12(12):CD009882. Paul O , Oh . An update of teriflunomide for treatment of multiple sclerosis[J]. Therapeutics and Clinical Risk Management, 2013:177-.